EA201992619A2 - Агонисты ppar, соединения, фармацевтические композиции и способы их применения - Google Patents

Агонисты ppar, соединения, фармацевтические композиции и способы их применения

Info

Publication number
EA201992619A2
EA201992619A2 EA201992619A EA201992619A EA201992619A2 EA 201992619 A2 EA201992619 A2 EA 201992619A2 EA 201992619 A EA201992619 A EA 201992619A EA 201992619 A EA201992619 A EA 201992619A EA 201992619 A2 EA201992619 A2 EA 201992619A2
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
ways
application
pharmaceutical compositions
ppar agonists
Prior art date
Application number
EA201992619A
Other languages
English (en)
Other versions
EA039833B1 (ru
EA201992619A3 (ru
Inventor
Майкл Даунс
Рональд М. Эванс
Артур Клюге
Бхарат Лагу
Масанори Миура
Сунил Кумар Паниграхи
Майкл Патейн
Сусанта Самаждар
Рамеш Сенайар
Тайсуке Такахаши
Original Assignee
Митобридж, Инк.
Дзе Солк Инститьют Фор Байолоджикал Стадиз
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Митобридж, Инк., Дзе Солк Инститьют Фор Байолоджикал Стадиз filed Critical Митобридж, Инк.
Publication of EA201992619A2 publication Critical patent/EA201992619A2/ru
Publication of EA201992619A3 publication Critical patent/EA201992619A3/ru
Publication of EA039833B1 publication Critical patent/EA039833B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)

Abstract

В настоящем изобретении представлены соединения и композиции, которые применимы при повышении активности PPAR. Представленные в настоящем изобретении соединения и композиции применимы для лечения связанных с PPAR заболеваний (например, мышечных заболеваний, сосудистых заболеваний, демиелинизирующих заболеваний и метаболических заболеваний).
EA201992619A 2016-06-20 2016-10-05 Агонисты ppar, соединения, фармацевтические композиции и способы их применения EA039833B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662352348P 2016-06-20 2016-06-20

Publications (3)

Publication Number Publication Date
EA201992619A2 true EA201992619A2 (ru) 2020-03-31
EA201992619A3 EA201992619A3 (ru) 2020-05-31
EA039833B1 EA039833B1 (ru) 2022-03-17

Family

ID=69942819

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201992618A EA039771B1 (ru) 2016-06-20 2016-10-05 Агонисты ppar, соединения, фармацевтические композиции и способы их применения
EA201992619A EA039833B1 (ru) 2016-06-20 2016-10-05 Агонисты ppar, соединения, фармацевтические композиции и способы их применения

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA201992618A EA039771B1 (ru) 2016-06-20 2016-10-05 Агонисты ppar, соединения, фармацевтические композиции и способы их применения

Country Status (1)

Country Link
EA (2) EA039771B1 (ru)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004060367A1 (en) * 2002-12-30 2004-07-22 Fujisawa Pharmaceutical Co., Ltd. Imidazole and triazole derivatives useful as selective cox-1 inhibitors
CA2908695A1 (en) * 2013-04-05 2014-10-09 Salk Institute For Biological Studies Ppar agonists

Also Published As

Publication number Publication date
EA039833B1 (ru) 2022-03-17
EA201992618A3 (ru) 2020-05-31
EA201992618A2 (ru) 2020-03-31
EA201992619A3 (ru) 2020-05-31
EA039771B1 (ru) 2022-03-11

Similar Documents

Publication Publication Date Title
EA201890776A1 (ru) Агонисты ppar, соединения, фармацевтические композиции и способы их применения
EA201890725A1 (ru) Агонисты фарнезоидного х-рецептора и их применение
EA201891203A1 (ru) Гетероциклические соединения в качестве иммуномодуляторов
EA201791874A1 (ru) Фторированные ингибиторы лизилоксидазоподобного фермента-2 и их применение
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201692201A1 (ru) Соединения и композиции в качестве агонистов toll-подобного рецептора 7
EA201691516A1 (ru) Дигидропирролопиридиновые ингибиторы ror-гамма
EA201692177A1 (ru) Соединения и композиции в качестве агонистов toll-подобного рецептора 7
BR112018069930A2 (pt) agonistas de ppar, compostos, composições farmacêuticas, e métodos de uso dos mesmos
MX2017016134A (es) Aril dihidro-2h-benzo[b][1,4]oxazina sulfonamida y compuestos relacionados para uso como agonistas de rory y el tratamiento de enfermedad.
EA201692109A1 (ru) Варианты антител к фактору d и их применение
EA201990400A1 (ru) Соединения и композиции и их применение
WO2015171558A3 (en) BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
EA201890449A1 (ru) Фумагиллиновые гетероциклические соединения и способы их получения и применения
EA201892475A1 (ru) Оксабороловые сложные эфиры, их применение
EA201792571A1 (ru) Терапевтическое применение l-4-хлорокинуренина
EA201892265A1 (ru) Способы лечения офтальмологических заболеваний
MX2022002635A (es) Anticuerpos anti proteina similar a angiopoyetina 4 y metodos de uso.
EA202090270A1 (ru) Новые замещенные производные ксантина
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
EA202091112A1 (ru) Сокристаллы, фармацевтические композиции на их основе и способы лечения, предусматривающие их применение
EA201792085A1 (ru) Смешанные дисульфидные конъюгаты тиенопиридиновых соединений и их применение
EA202090266A1 (ru) Ингибиторы mpo для применения в медицине
WO2016057660A8 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
EA201992619A3 (ru) Агонисты ppar, соединения, фармацевтические композиции и способы их применения